Table 4 Clinical factors associated with the feasibility of localizing the nasogastric tube by the magnet tracking device.

From: Feasibility of a low-cost magnet tracking device in confirming nasogastric tube placement at point of care, a clinical trial

 

Feasible: N = 5

Not feasible: N = 5

Age (year)

55.2 (SD 17.31)

Median: 60 (range 25–67)

62.8 (SD 7.22)

Median: 61 (range 55–73)

Gender (% male)

40%

80%

Height (m)

1.61 (SD 0.07)

Median 1.6 (range 1.5–1.7)

1.63 (SD 0.05)

Median 1.62 (range 1.58–1.7)

Weight (kg)

56 (SD 7.42)

Median 55 (range 47–64)

64.3 (SD 7.19)

Median 61 (range 57–75)

Body-mass-index (kg/m2)

21.62 (SD 2.03)

Median 21.80 (range 18.36–23.80)

23.17 (SD 2.13)

Median 23.63 (range 21.72–27.55)

Chest circumference (cm)

 2nd intercostal space

84.8 (SD 8.76)

Median 840 (range 740–970)

88.18 (SD 13.40)

Median 914 (range 650–985)

 Xiphisternum

78.7 (SD 9.67)

Median 76.0 (range 71–95.5)

86.66 (SD 8.70)

Median 90.5 (range 73–95.5)

 Umbilicus

80.0 (SD 9.87)

Median 80.5 (range 69 –94.5)

75.8 (24.63)

Median 90.5 (range36–93)

Vertical distance (cm)

 From clavicle to 2nd intercostal space (sternal angle)

7.4 (SD 1.88)

Median 7.5 (range 5.5–9.5)

7.6 (SD 2.90)

Median 6.0 (range 5.5–12.5)

 From 2nd intercostal space (sternal angle) to xiphisternum

11.2 (SD 2.36)

Median 12.0 (range 8.5–14.0)

14.4 (SD 1.85)

Median 15.0 (range 11.5–16.5)